The changing paradigm of intron retention: regulation, ramifications and recipes.
Monteuuis G, Wong JJL, Bailey CG, Schmitz U, Rasko JEJ. Nucleic Acids Res. 2019 Nov 14. PubMed
Aptamers as Modular Components of Therapeutic Nucleic Acid Nanotechnology.
Panigaj M, Johnson MB, Ke W, McMillan J, Goncharova EA, Chandler M, Afonin KA. ACS Nano. 2019 Nov 26;13(11):12301-12321. PubMed
The Role of Non-coding RNAs in Oncology.
Slack FJ, Chinnaiyan AM. Cell. 2019 Nov 14;179(5):1033-1055. PubMed
The biogenesis, biology and characterization of circular RNAs.
Kristensen LS, Andersen MS, Stagsted LVW, Ebbesen KK, Hansen TB, Kjems J. Nat Rev Genet. 2019 Nov;20(11):675-691. PubMed
Lipid-based nanoparticle formulations for small molecules and RNA drugs
Ickenstein LM, Garidel P. Expert Opin Drug Deliv. 2019 Sep 17. PubMed
Reactive modifications of DNA nucleobases for labelling, bioconjugations, and cross-linking
IvancovĂ¡ I, Leone DL, Hocek M. Curr Opin Chem Biol. 2019 Aug 12;52:136-144. PubMed
The roles of structural dynamics in the cellular functions of RNAs
Ganser LR, Kelly ML, Herschlag D, Al-Hashimi HM. Nat Rev Mol Cell Biol. 2019 Jun 10. PubMed
Pharmacokinetics and Clinical Pharmacology Considerations of GalNAc3-Conjugated Antisense Oligonucleotides
Wang Y, Yu RZ, Henry S, Geary RS. Expert Opin Drug Metab Toxicol. 2019 Jun;15(6):475-485. PubMed
Development and Application of Base Editors
Yang B, Yang L, Chen J. CRISPR J. 2019 Apr;2:91-104. PubMed
Guidelines for Experiments Using Antisense Oligonucleotides and Double-Stranded RNAs
Gagnon KT, Corey DR. Nucleic Acid Ther. 2019 Mar 23. PubMed